Recent advances in nanotechnology-based detection and separation of circulating tumor cells

Ja Hye Myung, Kevin A. Tam, Sin jung Park, Ashley Cha, Seungpyo Hong

Research output: Contribution to journalReview article

27 Citations (Scopus)

Abstract

Although circulating tumor cells (CTCs) in blood have been widely investigated as a potential biomarker for diagnosis and prognosis of metastatic cancer, their inherent rarity and heterogeneity bring tremendous challenges to develop a CTC detection method with clinically significant specificity and sensitivity. With advances in nanotechnology, a series of new methods that are highly promising have emerged to enable or enhance detection and separation of CTCs from blood. In this review, we systematically categorize nanomaterials, such as gold nanoparticles, magnetic nanoparticles, quantum dots, graphenes/graphene oxides, and dendrimers and stimuli-responsive polymers, used in the newly developed CTC detection methods. This will provide a comprehensive overview of recent advances in the CTC detection achieved through application of nanotechnology as well as the challenges that these existing technologies must overcome to be directly impactful on human health.

Original languageEnglish
Pages (from-to)223-239
Number of pages17
JournalWiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
Volume8
Issue number2
DOIs
Publication statusPublished - 2016 Mar 1

Fingerprint

Circulating Neoplastic Cells
Nanotechnology
Tumors
Cells
Nanoparticles
Blood
Dendrimers
Quantum Dots
Graphite
Nanostructures
Biomarkers
Nanostructured materials
Gold
Oxides
Graphene
Semiconductor quantum dots
Polymers
Health
Technology
Sensitivity and Specificity

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomedical Engineering

Cite this

@article{7f43774e505349128e7c5e2194b5796f,
title = "Recent advances in nanotechnology-based detection and separation of circulating tumor cells",
abstract = "Although circulating tumor cells (CTCs) in blood have been widely investigated as a potential biomarker for diagnosis and prognosis of metastatic cancer, their inherent rarity and heterogeneity bring tremendous challenges to develop a CTC detection method with clinically significant specificity and sensitivity. With advances in nanotechnology, a series of new methods that are highly promising have emerged to enable or enhance detection and separation of CTCs from blood. In this review, we systematically categorize nanomaterials, such as gold nanoparticles, magnetic nanoparticles, quantum dots, graphenes/graphene oxides, and dendrimers and stimuli-responsive polymers, used in the newly developed CTC detection methods. This will provide a comprehensive overview of recent advances in the CTC detection achieved through application of nanotechnology as well as the challenges that these existing technologies must overcome to be directly impactful on human health.",
author = "Myung, {Ja Hye} and Tam, {Kevin A.} and Park, {Sin jung} and Ashley Cha and Seungpyo Hong",
year = "2016",
month = "3",
day = "1",
doi = "10.1002/wnan.1360",
language = "English",
volume = "8",
pages = "223--239",
journal = "Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology",
issn = "1939-0041",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

Recent advances in nanotechnology-based detection and separation of circulating tumor cells. / Myung, Ja Hye; Tam, Kevin A.; Park, Sin jung; Cha, Ashley; Hong, Seungpyo.

In: Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Vol. 8, No. 2, 01.03.2016, p. 223-239.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Recent advances in nanotechnology-based detection and separation of circulating tumor cells

AU - Myung, Ja Hye

AU - Tam, Kevin A.

AU - Park, Sin jung

AU - Cha, Ashley

AU - Hong, Seungpyo

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Although circulating tumor cells (CTCs) in blood have been widely investigated as a potential biomarker for diagnosis and prognosis of metastatic cancer, their inherent rarity and heterogeneity bring tremendous challenges to develop a CTC detection method with clinically significant specificity and sensitivity. With advances in nanotechnology, a series of new methods that are highly promising have emerged to enable or enhance detection and separation of CTCs from blood. In this review, we systematically categorize nanomaterials, such as gold nanoparticles, magnetic nanoparticles, quantum dots, graphenes/graphene oxides, and dendrimers and stimuli-responsive polymers, used in the newly developed CTC detection methods. This will provide a comprehensive overview of recent advances in the CTC detection achieved through application of nanotechnology as well as the challenges that these existing technologies must overcome to be directly impactful on human health.

AB - Although circulating tumor cells (CTCs) in blood have been widely investigated as a potential biomarker for diagnosis and prognosis of metastatic cancer, their inherent rarity and heterogeneity bring tremendous challenges to develop a CTC detection method with clinically significant specificity and sensitivity. With advances in nanotechnology, a series of new methods that are highly promising have emerged to enable or enhance detection and separation of CTCs from blood. In this review, we systematically categorize nanomaterials, such as gold nanoparticles, magnetic nanoparticles, quantum dots, graphenes/graphene oxides, and dendrimers and stimuli-responsive polymers, used in the newly developed CTC detection methods. This will provide a comprehensive overview of recent advances in the CTC detection achieved through application of nanotechnology as well as the challenges that these existing technologies must overcome to be directly impactful on human health.

UR - http://www.scopus.com/inward/record.url?scp=84959246462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959246462&partnerID=8YFLogxK

U2 - 10.1002/wnan.1360

DO - 10.1002/wnan.1360

M3 - Review article

C2 - 26296639

AN - SCOPUS:84959246462

VL - 8

SP - 223

EP - 239

JO - Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

JF - Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

SN - 1939-0041

IS - 2

ER -